GlycoMimetics Raises $38 Million
GlycoMimetics, a Gaithersburg, Md.-based developer of glycobiology-based therapies, has raised $38 million in third-round funding. Genzyme Ventures was joined by return backers New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures. The company previously raised around $25 million.
21 October 2009•3 mins read
